SurgLine International Overview
Valuation check: SGLN's ROE is 176.34%, above the Technology sector average of 47.1%.
Get informed when a big investor buys or sells
+ Follow176.34%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for SGLN is 176.34%. That is above the Technology sector average of 47.1%. Investors often review this figure alongside SurgLine International's historical trend and sector peers before judging valuation or financial health.
Against Technology companies, SGLN currently prints 176.34% for ROE, while the sector average sits near 47.1%. That is roughly 274.4% above the sector mean. Large gaps often invite a closer look at SurgLine International's growth, margins, and balance sheet.
Return on Equity shows how effectively SurgLine International converts resources into returns. At 176.34%, SGLN may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting SGLN's ROE (176.34%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack SurgLine International's ROE against similar Technology names. You can also browse sector and industry screens on Stockcircle for a broader set of Technology companies and their key multiples and fundamentals.
